ARCHIVES

In Brief: Chabner Says He ”Has No Intention Of Leaving NCI; “Yarbro Named Clinical Indicators Chairman

This article is from The Cancer Letter archive.

Vol. 14 No. 36 | September 2, 1988

Download PDF Visit The Full Archive

Related Articles

FDA News:: ODAC Commends Ciba For Design Of Trials Legal Issues:

January 10, 1997

Genentech Reps Not Welcome: Hospitals Urge Drug Maker to Reverse Policy On Supplying Avastin, Rituxan, & Herceptin

October 17, 2014

UPCI Clarifies Agreement Between Eli Lilly And PCRN.

July 27, 2001

More Aggressive Prevention, Detection Could Save Lives, Cancer Policy Board Says

March 28, 2003

Cancer Centers Could Form Network for Genetics Research, NCI Says

April 12, 1996

NIH Panel finalizes Consensus Statement; Two Panelists Join In Minority Opinion

March 28, 1997